Oncogenic osteomalacia (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Oncogenic osteomalacia" in English language version.

refsWebsite

Global rank English rank

16nih.gov

4^th place

11doi.org

2^nd place

1harvard.edu

18^th place

17^th place

doi.org

Kaur T, Rush ET, Bhattacharya RK (March 2019). "Phosphaturic Mesenchymal Heel Tumor Presenting with Tumor-Induced Osteomalacia". AACE Clinical Case Reports. 5 (2): e138 – e141. doi:10.4158/ACCR-2018-0300. PMC 6873860. PMID 31967019.
Jan de Beur SM (September 2005). "Tumor-induced osteomalacia". JAMA. 294 (10): 1260–1267. doi:10.1001/jama.294.10.1260. PMID 16160135.
Chong WH, Molinolo AA, Chen CC, Collins MT (June 2011). "Tumor-induced osteomalacia". Endocrine-Related Cancer. 18 (3): R53 – R77. doi:10.1530/ERC-11-0006. PMC 3433741. PMID 21490240.
Carpenter TO (April 2003). "Oncogenic osteomalacia--a complex dance of factors". The New England Journal of Medicine. 348 (17): 1705–1708. doi:10.1056/NEJMe030037. PMID 12711747.
Wasserman JK, Purgina B, Lai CK, Gravel D, Mahaffey A, Bell D, Chiosea SI (September 2016). "Phosphaturic Mesenchymal Tumor Involving the Head and Neck: A Report of Five Cases with FGFR1 Fluorescence In Situ Hybridization Analysis". Head and Neck Pathology. 10 (3): 279–285. doi:10.1007/s12105-015-0678-1. PMC 4972751. PMID 26759148.
Zadik Y, Nitzan DW (February 2012). "Tumor induced osteomalacia: a forgotten paraneoplastic syndrome?". Oral Oncology. 48 (2): e9-10. doi:10.1016/j.oraloncology.2011.09.011. PMID 21985764.
Shimada T, Mizutani S, Muto T, Yoneya T, Hino R, Takeda S, et al. (May 2001). "Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia". Proceedings of the National Academy of Sciences of the United States of America. 98 (11): 6500–6505. Bibcode:2001PNAS...98.6500S. doi:10.1073/pnas.101545198. PMC 33497. PMID 11344269.
Berndt T, Craig TA, Bowe AE, Vassiliadis J, Reczek D, Finnegan R, et al. (September 2003). "Secreted frizzled-related protein 4 is a potent tumor-derived phosphaturic agent". The Journal of Clinical Investigation. 112 (5): 785–794. doi:10.1172/JCI18563. PMC 182208. PMID 12952927.
Rowe PS, de Zoysa PA, Dong R, Wang HR, White KE, Econs MJ, Oudet CL (July 2000). "MEPE, a new gene expressed in bone marrow and tumors causing osteomalacia". Genomics. 67 (1): 54–68. doi:10.1006/geno.2000.6235. PMID 10945470.
Clifton-Bligh RJ, Hofman MS, Duncan E, Sim I, Darnell D, Clarkson A, et al. (February 2013). "Improving diagnosis of tumor-induced osteomalacia with Gallium-68 DOTATATE PET/CT". The Journal of Clinical Endocrinology and Metabolism. 98 (2): 687–694. doi:10.1210/jc.2012-3642. PMID 23295468.
Geller JL, Khosravi A, Kelly MH, Riminucci M, Adams JS, Collins MT (June 2007). "Cinacalcet in the management of tumor-induced osteomalacia". Journal of Bone and Mineral Research. 22 (6): 931–937. doi:10.1359/jbmr.070304. PMID 17352646.

harvard.edu

ui.adsabs.harvard.edu

Shimada T, Mizutani S, Muto T, Yoneya T, Hino R, Takeda S, et al. (May 2001). "Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia". Proceedings of the National Academy of Sciences of the United States of America. 98 (11): 6500–6505. Bibcode:2001PNAS...98.6500S. doi:10.1073/pnas.101545198. PMC 33497. PMID 11344269.

nih.gov

pubmed.ncbi.nlm.nih.gov

Kaur T, Rush ET, Bhattacharya RK (March 2019). "Phosphaturic Mesenchymal Heel Tumor Presenting with Tumor-Induced Osteomalacia". AACE Clinical Case Reports. 5 (2): e138 – e141. doi:10.4158/ACCR-2018-0300. PMC 6873860. PMID 31967019.
Jan de Beur SM (September 2005). "Tumor-induced osteomalacia". JAMA. 294 (10): 1260–1267. doi:10.1001/jama.294.10.1260. PMID 16160135.
Chong WH, Molinolo AA, Chen CC, Collins MT (June 2011). "Tumor-induced osteomalacia". Endocrine-Related Cancer. 18 (3): R53 – R77. doi:10.1530/ERC-11-0006. PMC 3433741. PMID 21490240.
Carpenter TO (April 2003). "Oncogenic osteomalacia--a complex dance of factors". The New England Journal of Medicine. 348 (17): 1705–1708. doi:10.1056/NEJMe030037. PMID 12711747.
Wasserman JK, Purgina B, Lai CK, Gravel D, Mahaffey A, Bell D, Chiosea SI (September 2016). "Phosphaturic Mesenchymal Tumor Involving the Head and Neck: A Report of Five Cases with FGFR1 Fluorescence In Situ Hybridization Analysis". Head and Neck Pathology. 10 (3): 279–285. doi:10.1007/s12105-015-0678-1. PMC 4972751. PMID 26759148.
Zadik Y, Nitzan DW (February 2012). "Tumor induced osteomalacia: a forgotten paraneoplastic syndrome?". Oral Oncology. 48 (2): e9-10. doi:10.1016/j.oraloncology.2011.09.011. PMID 21985764.
Shimada T, Mizutani S, Muto T, Yoneya T, Hino R, Takeda S, et al. (May 2001). "Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia". Proceedings of the National Academy of Sciences of the United States of America. 98 (11): 6500–6505. Bibcode:2001PNAS...98.6500S. doi:10.1073/pnas.101545198. PMC 33497. PMID 11344269.
Berndt T, Craig TA, Bowe AE, Vassiliadis J, Reczek D, Finnegan R, et al. (September 2003). "Secreted frizzled-related protein 4 is a potent tumor-derived phosphaturic agent". The Journal of Clinical Investigation. 112 (5): 785–794. doi:10.1172/JCI18563. PMC 182208. PMID 12952927.
Rowe PS, de Zoysa PA, Dong R, Wang HR, White KE, Econs MJ, Oudet CL (July 2000). "MEPE, a new gene expressed in bone marrow and tumors causing osteomalacia". Genomics. 67 (1): 54–68. doi:10.1006/geno.2000.6235. PMID 10945470.
Clifton-Bligh RJ, Hofman MS, Duncan E, Sim I, Darnell D, Clarkson A, et al. (February 2013). "Improving diagnosis of tumor-induced osteomalacia with Gallium-68 DOTATATE PET/CT". The Journal of Clinical Endocrinology and Metabolism. 98 (2): 687–694. doi:10.1210/jc.2012-3642. PMID 23295468.
Geller JL, Khosravi A, Kelly MH, Riminucci M, Adams JS, Collins MT (June 2007). "Cinacalcet in the management of tumor-induced osteomalacia". Journal of Bone and Mineral Research. 22 (6): 931–937. doi:10.1359/jbmr.070304. PMID 17352646.

ncbi.nlm.nih.gov

Kaur T, Rush ET, Bhattacharya RK (March 2019). "Phosphaturic Mesenchymal Heel Tumor Presenting with Tumor-Induced Osteomalacia". AACE Clinical Case Reports. 5 (2): e138 – e141. doi:10.4158/ACCR-2018-0300. PMC 6873860. PMID 31967019.
Chong WH, Molinolo AA, Chen CC, Collins MT (June 2011). "Tumor-induced osteomalacia". Endocrine-Related Cancer. 18 (3): R53 – R77. doi:10.1530/ERC-11-0006. PMC 3433741. PMID 21490240.
Wasserman JK, Purgina B, Lai CK, Gravel D, Mahaffey A, Bell D, Chiosea SI (September 2016). "Phosphaturic Mesenchymal Tumor Involving the Head and Neck: A Report of Five Cases with FGFR1 Fluorescence In Situ Hybridization Analysis". Head and Neck Pathology. 10 (3): 279–285. doi:10.1007/s12105-015-0678-1. PMC 4972751. PMID 26759148.
Shimada T, Mizutani S, Muto T, Yoneya T, Hino R, Takeda S, et al. (May 2001). "Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia". Proceedings of the National Academy of Sciences of the United States of America. 98 (11): 6500–6505. Bibcode:2001PNAS...98.6500S. doi:10.1073/pnas.101545198. PMC 33497. PMID 11344269.
Berndt T, Craig TA, Bowe AE, Vassiliadis J, Reczek D, Finnegan R, et al. (September 2003). "Secreted frizzled-related protein 4 is a potent tumor-derived phosphaturic agent". The Journal of Clinical Investigation. 112 (5): 785–794. doi:10.1172/JCI18563. PMC 182208. PMID 12952927.